78
主要从事手抓饼等饼类食品的研发、生产、
仓储配送、 销售以及国际贸易业务。业务
范围覆盖全国各省市,通过连锁加盟模式开
设的手抓饼门店峰值数达 12000 多家 , 同期
增长率达 200% 以上。海外市场有美国、英
国、加拿大、韩国、澳大利亚、新西兰、新
加坡、马来西 亚、印尼、越南等 20 余个国家。
是国家高新技术企业及海南省技术先进型服
务企业,是国内第一家在美国申报 ANDA
并通过 BE 实验的制药企业。公司在高新
区实现 2020 年营收 8219 万元,并逐年以
23% 年增长率增长,出口产品占公司销售
产品总量的 65%。公司现有主打产品琥珀
酸美托洛尔缓释片和恩替卡韦片均获得美国
FDA 认证。
Food
Medicine
项目一期建成,进口面粉原料年需求量为
30000 吨,进口油脂年需求量为 8000 吨。
项目二期投设 4 条烤肉生产线,配备 40 台
自动化烤肉机,自烤自削每天产能 80 吨肉
品,可实现年产能 24000 吨,每天消耗 110
吨进口原肉,年消耗 33000 吨原肉。
目前公司主要生产所需原材料均从美国进
口原材料(细则后附列表),2020 年共进
口物料总价为 367.69 万元,总计免税金额
为 99.27 万元。因新建厂房产能的扩充,预
计在新厂房达产后,预计进口物料总价为
2867 万元,预计免税金额将达到 774 万元。
食品
医药
It is mainly engaged in shredded cake and
other cake food research and development,
production, warehousing distribution, sales
and international trade business. Its business
scope covers all provinces and cities across
the country. The peak number of shredded
cake stores opened through franchise mode
reached more than 12,000, with a growth rate
of more than 200% in the same period. Its
overseas market has expanded to the United
States, the United Kingdom, Canada, South
Korea, Australia, New Zealand, Singapore,
Malaysia, Indonesia, Vietnam and other more
than 20 countries.
It is a national high-tech enterprise and a
technology-advanced service enterprise in
Hainan Province. It is the first pharmaceutical
enterprise in China that has applied for ANDA
in the United States and passed the BE test.
The company achieved revenue of RMB
82.19 million in 2020, and is increasing in the
annual growth rate of 23% year by year, and
its export products account for 65% of the
total sales of the company. The main products
of the company are Metoprolol Succinate
Sustained Release Tablets and Entecavir
Tablets, both of which have been approved by
FDA of the US.
After the completion of Phase I of the project,
the annual demand for imported flour raw
materials is 30,000 tons, and the annual
demand for imported oil is 8,000 tons. It is
to plan to invest 4 barbecue production lines
in Phase IV, equipping with 40 automatic
barbecue machines, with a daily capacity of
80 tons of meat, which can achieve an annual
capacity of 24,000 tons, consuming 110 tons
of imported raw meat per day and 33,000
tons of raw meat per year.
At present, the company mainly imports raw
materials needed for production from the
United States (attached to the list of details).
In 2020, the total price of imported materials
was RMB 3,676,900, with the total duty-free
amount reaching RMB 992,700. Due to the
expansion of the capacity of the new plant, it
is estimated that after the new plant reaching
design capacity, the total price of imported
materials shall be RMB 28.67 million, and
the duty-free amount shall reach RMB 7.74
million.